Role of cholecystokinin in the anorexia produced by duodenal delivery of oleic acid in rats.
To assess the importance of triglyceride digestion products in producing satiety, we determined the effects of duodenal infusions of triolein, oleic acid, and oleic acid plus monoolein on meal patterns in ad libitum-feeding rats. Oleic acid and oleic acid plus monoolein inhibited feeding similarly; triolein's effect was delayed and fourfold less potent. We then used the type A cholecystokinin (CCK-A)-receptor antagonist devazepide to assess the importance of CCK in mediating the anorexia produced by oleic acid. Oleic acid (at 320, 440, and 640 mumol/h) inhibited 3-h intake dose dependently by 32, 56, and 75%, respectively. Devazepide (1 or 2 mg/kg) blocked the responses to the 320 mumol/h dose, but had little if any effect on responses to the larger doses. Devazepide (1 mg/kg) did block anorexic responses to 3-h cholecystokinin octapeptide infusions (3 and 10 nmol.kg-1.h-1 iv) that inhibited 3-h intake by 25 and 65%, respectively. Our results suggest that the satiety response to triolein is produced by the products of triolein digestion and that CCK plays a significant, indispensable role in mediating the satiety response to duodenal delivery of small but not large loads of oleic acid.
Woltman
T
T
Veterans Affairs Medical Center, Omaha 68105, USA.
Castellanos
D
D
Reidelberger
R
R
D000818:Animals; D000855:Anorexia / Q000503:physiopathology*; D001570:Benzodiazepinones / Q000494:pharmacology; D002404:Catheterization; D002766:Cholecystokinin / Q000502:physiology*; D020109:Devazepide; D004063:Digestion; D004386:Duodenum / Q000502:physiology*; D004435:Eating / Q000187:drug effects; D005247:Feeding Behavior / Q000502:physiology; D008297:Male; D019301:Oleic Acid; D009829:Oleic Acids / Q000008:administration & dosage* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012528:Satiety Response; D012844:Sincalide / Q000494:pharmacology; D014304:Triolein / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology
D001570:Benzodiazepinones; D009829:Oleic Acids; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; D014304:Triolein; D019301:Oleic Acid; D002766:Cholecystokinin; D020109:Devazepide; D012844:Sincalide